MARKER THERAPEUTICS, INC. (NASDAQ: MRKR) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.

Marker Therapeutics, Inc. Exhibit
EX-99.1 2 tv507987_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1     The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting   –Three abstracts accepted,…
To view the full exhibit click here